Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy B Niewold

Showing results (21-30 of 181) with videos related to

Pageof 19
Sort By:
The Journal of Investigative Dermatology|January 12, 2022
Type I Interferons in AutoimmunityRuth Fernandez-Ruiz, Timothy B Niewold
Clinical Rheumatology|November 27, 2004
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis CTimothy B Niewold, William I Swedler
Mayo Clinic Proceedings|December 15, 2004
59-year-old woman with progressive dyspnea on exertionTimothy B Niewold, Jay H Ryu
Expert Opinion on Investigational Drugs|July 24, 2020
Type I interferon antagonists in clinical development for lupusJacqueline L Paredes, Timothy B Niewold
International Journal of Clinical Rheumatology|January 14, 2014
Genetics of the type I interferon pathway in systemic lupus erythematosusYogita Ghodke-Puranik, Timothy B Niewold
Drug Design, Development and Therapy|March 24, 2017
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to dateAleksander Lenert, Timothy B Niewold, Petar Lenert
Nature Reviews. Rheumatology|March 22, 2018
Type I interferon in rheumatic diseasesTheresa L Wampler Muskardin, Timothy B Niewold
Clinical & Developmental Immunology|December 20, 2012
Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosusCandace M Cham, Kichul Ko, Timothy B Niewold
Journal of Immunology Research|August 29, 2014
Autoimmune disease genetics 2013Timothy B Niewold, George N Goulielmos, Shervin Assassi
Gene|September 28, 2015
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseasesConsuelo M López de Padilla, Timothy B Niewold
Pageof 19

Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
The Journal of Investigative Dermatology|January 12, 2022
Type I Interferons in AutoimmunityRuth Fernandez-Ruiz, Timothy B Niewold
Clinical Rheumatology|November 27, 2004
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis CTimothy B Niewold, William I Swedler
Mayo Clinic Proceedings|December 15, 2004
59-year-old woman with progressive dyspnea on exertionTimothy B Niewold, Jay H Ryu
Expert Opinion on Investigational Drugs|July 24, 2020
Type I interferon antagonists in clinical development for lupusJacqueline L Paredes, Timothy B Niewold
International Journal of Clinical Rheumatology|January 14, 2014
Genetics of the type I interferon pathway in systemic lupus erythematosusYogita Ghodke-Puranik, Timothy B Niewold
Drug Design, Development and Therapy|March 24, 2017
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to dateAleksander Lenert, Timothy B Niewold, Petar Lenert
Nature Reviews. Rheumatology|March 22, 2018
Type I interferon in rheumatic diseasesTheresa L Wampler Muskardin, Timothy B Niewold
Clinical & Developmental Immunology|December 20, 2012
Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosusCandace M Cham, Kichul Ko, Timothy B Niewold
Journal of Immunology Research|August 29, 2014
Autoimmune disease genetics 2013Timothy B Niewold, George N Goulielmos, Shervin Assassi
Gene|September 28, 2015
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseasesConsuelo M López de Padilla, Timothy B Niewold
Pageof 19